FDA Approves Cosentyx

FDA Approves Cosentyx


The U.S. Food and Drug Administration has
approved Cosentyx to treat adults with moderate-to-severe plaque psoriasis. Plaque psoriasis is an autoimmune disorder
in which patients develop thick, red skin with flaky, silver-white patches called scales. For more information on Cosentyx visit RxWiki.com.

Leave a Reply

Your email address will not be published. Required fields are marked *